Incompatible bone-marrow transplantation in lymphopenic immunologic deficiency. Circumvention of fatal graft-versus-host disease by immunologic enhancement.
D000361:Agammaglobulinemia / Q000235:genetics / Q000628:therapy*; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000941:Antigens; D001772:Blood Cell Count; D001831:Body Temperature; D016026:Bone Marrow Transplantation; D002175:Candida / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006128:Growth; D006648:Histocompatibility; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007165:Immunosuppression Therapy; D007223:Infant; D007231:Infant, Newborn; D008198:Lymph Nodes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008231:Lymphopenia / Q000235:genetics / Q000628:therapy*; D010375:Pedigree; D012756:Sheep; D012882:Skin Tests; D013950:Thymus Gland / Q000637:transplantation; D014184:Transplantation, Homologous
D000906:Antibodies; D000941:Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M